Manufacturer copay assistance · Enhertu (J9358) · Daiichi Sankyo / AstraZeneca
$0/dose · Maximum benefit Up to $26,000 per calendar year, may also cover up to $100 in infusion costs per administration · Covers Enhertu drug cost and up to $100 per administration in infusion costs
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Enhertu — the program's cap applies against the patient share CareCost calculates.
Yes — ENHERTU4U Patient Savings Program from Daiichi Sankyo / AstraZeneca. Eligible patients may pay as little as $0 per Enhertu prescription. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay as little as $0 per Enhertu prescription Maximum benefit: Up to $26,000 per calendar year, may also cover up to $100 in infusion costs per administration. Covers Enhertu drug cost and up to $100 per administration in infusion costs
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.